Patents by Inventor Franz Rovenszky
Franz Rovenszky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6342517Abstract: Novel thienopyran compounds are disclosed, useful as anti-hypertensive agents and for asthma treatment. One group of the compounds has a heterocyclic ring spiro-connected at the 7-position of the thienopyran ring structure. Use of thienopyran compounds in hair growth modulation is described.Type: GrantFiled: December 3, 1999Date of Patent: January 29, 2002Assignee: Cambridge Bioclinical LimitedInventors: Peter Esch, Franz Rovenszky, Robertson Towart, Thomas Christoph, Michael Hartmann, George Terence Evelyn Kealey
-
Patent number: 6297282Abstract: The present application relates to compounds of formula (I) wherein A represents oxygen, sulfur or —NH—, m is 0-2, and R1, R2, R3, R6 and R7 have the meanings given in the specification, to a process for their preparation, as well as to their use in the inhibition of cyclooxygenase II.Type: GrantFiled: October 26, 1999Date of Patent: October 2, 2001Assignee: Nycomed Austria GmbHInventors: Michael Hartmann, Peter Kremminger, Heinz Blaschke, Dagmar Stimmeder, Harald Fellier, Franz Rovenszky
-
Patent number: 6197793Abstract: Novel compounds of general formula (I) which have homoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.Type: GrantFiled: December 4, 1998Date of Patent: March 6, 2001Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbHInventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
-
Patent number: 6191146Abstract: The present invention relates to novel compounds which have hemoregulatory activities and can be used to stimulate hematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.Type: GrantFiled: April 1, 1999Date of Patent: February 20, 2001Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbHInventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, James Francis Callahan, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
-
Patent number: 6150524Abstract: Morphine derivatives of formula (I), process for perparing them and their use and use as analgesics.Type: GrantFiled: December 8, 1998Date of Patent: November 21, 2000Assignee: CeNeS Ltd.Inventors: Michael Hartmann, Dagmar Stimmeder, Steinar Engelsen, Andreas Koch, Franz Rovenszky, Peter Kremminger, Michael Hutzinger
-
Patent number: 6124298Abstract: The present invention relates to novel pyrazine compounds and their use in the regulation of haematopoiesis, in particular in the stimulation of haematopoiesis, and in the treatment of bacterial, viral and fungal diseases.Type: GrantFiled: August 20, 1999Date of Patent: September 26, 2000Assignee: Nycomed Imaging ASInventors: Jessie Sandosham, Johann Hiebl, Hermann Kollmann, Alan Cuthbertson, Peter Fischer, Michael Hartmann, Peter Kremminger, Franz Rovenszky, Mette Husbyn
-
Patent number: 6114357Abstract: Novel compounds of general formula (1), which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.Type: GrantFiled: February 9, 1999Date of Patent: September 5, 2000Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbHInventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
-
Patent number: 6107309Abstract: The present invention relates to novel compounds which have hemoregulatory activities and can be used to stimulate hematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.Type: GrantFiled: December 4, 1998Date of Patent: August 22, 2000Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbHInventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, James Francis Callahan, Johann Hiebl, Michael Hartmann, Peter Kremminger, Franz Rovenszky
-
Patent number: 6077855Abstract: Novel compounds of the general formula (I) which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.Type: GrantFiled: December 4, 1998Date of Patent: June 20, 2000Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbHInventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
-
Patent number: 6077856Abstract: Novel compounds of the general formula (I) which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases ##STR1##Type: GrantFiled: December 14, 1998Date of Patent: June 20, 2000Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbHInventors: Pradip Kumar Bhatnagar, Dirk Andries Heerding, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
-
Patent number: 6051584Abstract: Novel compounds of the general formula (I) which have hemoregulatory activities and can be used to stimulate haematopolesis and for the treatment of viral, fungal and bacterial infectious diseases ##STR1##Type: GrantFiled: November 23, 1998Date of Patent: April 18, 2000Assignees: SmithKline Beecham Corporation, Nycomed Austria GmbHInventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
-
Patent number: 6030989Abstract: Novel compounds of general formula (I) which have hemoregulatory activities and can be used to stimulate haematopoiesis and for the treatment of viral, fungal and bacterial infectious diseases.Type: GrantFiled: November 23, 1998Date of Patent: February 29, 2000Assignee: SmithKline Beecham CorporationInventors: Pradip Kumar Bhatnagar, Michael Hartmann, Johann Hiebl, Peter Kremminger, Franz Rovenszky
-
Patent number: 6004948Abstract: Compounds of the formula (I) in which A is oxygen, sulphur or NH; B is a group of the formula (IIa) or (IIb); and the other variables have the meaning given in claim 1, may be used as inhibitors of the enzyme cyclooxygenase II ##STR1##Type: GrantFiled: September 3, 1998Date of Patent: December 21, 1999Assignee: Nycomed Austria GmbHInventors: Heinz Blaschke, Peter Kremminger, Michael Hartmann, Harald Fellier, Jorg Berg, Thomas Christoph, Franz Rovenszky, Dagmar Stimmeder
-
Patent number: 5972926Abstract: The present invention relates to pyrazine fused to a cyclic peptide which is capable of regulating, in particular stimulating, haematopoiesis.Type: GrantFiled: June 5, 1998Date of Patent: October 26, 1999Assignee: Nycomed Imaging ASInventors: Jessie Sandosham, Johann Hiebl, Hermann Kollmann, Alan Cuthbertson, Peter Fischer, Michael Hartmann, Peter Kremminger, Franz Rovenszky, Mette Husbyn
-
Patent number: 5643438Abstract: The invention relates to a new process for the preparation of substituted diaminodicarboxylic acid derivatives of the formula ##STR1## in a high yield by a modified Kolbe synthesis.Type: GrantFiled: June 5, 1995Date of Patent: July 1, 1997Assignee: Hafslund Nycomed Pharma AktiengesellschaftInventors: Johann Hiebl, Franz Rovenszky
-
Patent number: 5627198Abstract: The invention relates to heterocyclic amides of the formula ##STR1## in which the radicals A, Z, A.sub.1, R.sub.1, R.sub.2 and R.sub.3 are as defined in the description, to a process for the preparation of these amides and to their use as active substances for the curing and amelioration of disorders and diseases which can be treated by exerting influence on potassium channels.Type: GrantFiled: December 4, 1995Date of Patent: May 6, 1997Assignee: Hafslund Nycomed Pharma AktiengesellschaftInventors: Peter Esch, Robertson Towart, Franz Rovenszky
-
Patent number: 5627302Abstract: The invention relates to novel asymmetrically substituted diaminodicarboxylic acid derivatives of the formula ##STR1##Type: GrantFiled: April 24, 1996Date of Patent: May 6, 1997Assignee: Hafslund Nycomed Pharma AktiengesellschaftInventors: Johann Hiebl, Franz Rovenszky
-
Patent number: 5100911Abstract: Thienyloxyalkylamine derivatives of the general formula: ##STR1## wherein --O--CH.sub.2 --CH.sub.2 --NR.sub.2 R.sub.3 is in position 4 or 5 of the thiophene ring;R.sub.1 is hydrogen, halogen, CF.sub.3, alkyl or alkoxy;R.sub.2 and R.sub.3 are the same or different and are each alkyl, cycloalkyl, alkenyl or alkynyl each having up to 8 C atoms, or NR.sub.2 R.sub.3 is a 5 to 7-membered saturated heterocyclic ring optionally containing a further hetero atom which is oxygen or nitrogen optionally substituted by an alkyl group having 1 to 3 C atoms; andn is an integer of 1 to 5; as well as their acid addition salts, are suitable for treatment of heart rhythm disturbances.Type: GrantFiled: May 15, 1990Date of Patent: March 31, 1992Assignee: Ebewe Arzneimittel Gesellschaft m.b.H.Inventors: Dieter Binder, Gerhard Greier, Franz Rovenszky, Friedrich Hillebrand
-
Patent number: 5086180Abstract: Sulphamoylathiophenes of the formula ##STR1## in which Y denotes O or S,A denotes a single bond or a straight-chain or branched alkylene group having 1-5 carbon atoms,R.sub.1 denotes methyl or trifluoromethyl andR.sub.2 denotes hydrogen or a group COOH or COOR.sub.3, in whichR.sub.3 represents (C.sub.1 -C.sub.4)-alkyl,and, in the case in which R.sub.2 denotes a group COOH, their pharmaceutically tolerable salts, a process for their preparation, pharmaceutical preparations which contain these compounds and their use in medicaments as leukotriene antagonists for the treatment of asthma and allergies.Type: GrantFiled: June 15, 1990Date of Patent: February 4, 1992Assignee: Chemisch Pharmazeutische Forschungsgesellschaft m.b.H.Inventors: Dieter Binder, Franz Rovenszky, Norman Brunner, Hubert P. Ferber
-
Patent number: 5077307Abstract: Thienopyran derivatives of the general formula ##STR1## in which the radial ##STR2## denotes one of the formulae ##STR3## R denotes hydrogen or a radical --CN, --CHO, --CH.dbd.NOH, --CONH.sub.2 or --COOR.sub.1,R.sub.1 denotes the radical (C.sub.1 -C.sub.4)-alkyl and n denotes an integer 3, 4 or 5, and a process for their preparation, pharmaceutical preparation and their use for the treatment of diseases which can be cured by activation of membrane K.sup.+ channels, such as high blood pressure and asthma.Type: GrantFiled: June 13, 1990Date of Patent: December 31, 1991Assignee: Chemisch Pharmazeutische Forschungsgesellschaft m.b.H.Inventors: Dieter Binder, Franz Rovenszky, Josef Weinberger, Hubert P. Ferber